Bala Rajni, Khanna Sushil, Pawar Pravin
Chitkara College of Pharmacy, Chandigarh-Patiala National Highway, Rajpura, Patiala, Punjab 140 401, India.
Crest Healthcare Pvt. Ltd., Baddi, Himachal Pradesh 173205, India.
J Drug Deliv. 2014;2014:392783. doi: 10.1155/2014/392783. Epub 2014 Sep 28.
Clobazam orally dissolving strips were prepared by solvent casting method. A full 3(2) factorial design was applied for optimization using different concentration of film forming polymer and disintegrating agent as independent variable and disintegration time, % cumulative drug release, and tensile strength as dependent variable. In addition the prepared films were also evaluated for surface pH, folding endurance, and content uniformity. The optimized film formulation showing the maximum in vitro drug release, satisfactory in vitro disintegration time, and tensile strength was selected for bioavailability study and compared with a reference marketed product (frisium5 tablets) in rabbits. Formulation (F6) was selected by the Design-expert software which exhibited DT (24 sec), TS (2.85 N/cm(2)), and in vitro drug release (96.6%). Statistical evaluation revealed no significant difference between the bioavailability parameters of the test film (F6) and the reference product. The mean ratio values (test/reference) of C max (95.87%), t max (71.42%), AUC0-t (98.125%), and AUC0-∞ (99.213%) indicated that the two formulae exhibited comparable plasma level-time profiles.
通过溶剂浇铸法制备氯巴占口腔崩解片。采用全3(2)析因设计进行优化,将不同浓度的成膜聚合物和崩解剂作为自变量,崩解时间、药物累积释放率和拉伸强度作为因变量。此外,还对制备的薄膜进行了表面pH值、耐折性和含量均匀度的评估。选择体外药物释放量最大、体外崩解时间和拉伸强度令人满意的优化薄膜制剂进行生物利用度研究,并与家兔体内的市售参比产品(Frisium5片)进行比较。通过Design-expert软件选择的制剂(F6)的崩解时间(DT,24秒)、拉伸强度(TS,2.85N/cm²)和体外药物释放率(96.6%)。统计评估显示,受试薄膜(F6)和参比产品的生物利用度参数之间无显著差异。Cmax(95.87%)、tmax(71.42%)、AUC0-t(98.125%)和AUC0-∞(99.213%)的平均比值(受试/参比)表明,两种制剂具有相似的血药浓度-时间曲线。